Therapeutic BCG Vaccines Global Market Report 2025

Global Therapeutic BCG Vaccines Market Report 2024

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

Name: Therapeutic BCG Vaccines Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Therapeutic BCG Vaccines Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Therapeutic BCG Vaccines Global Market Report 2025

Proud Members Of

Therapeutic BCG Vaccines Market Definition

Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.

The major types of therapeutic BCG vaccines are therapy BCG and immune BCG. Therapy BCG refers to a kind of intravesical immunotherapy that aids the immune system's destruction of cancer cells and is frequently used to treat bladder cancer in its early stages. By demographics, BCG vaccines can be used on pediatrics and adults. These are used by several end-users, such as hospitals, clinics, and other end-users.

Therapeutic BCG Vaccines Market Segmentation

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Immune BCG

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

Subsegments:

1) By Therapy BCG: Intravesical BCG, Injectable BCG

2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment

Therapeutic BCG Vaccines Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

Therapeutic BCG Vaccines Market Size 2025 And Growth Rate

The therapeutic bcg vaccines market size has grown strongly in recent years. It will grow from $56.47 billion in 2024 to $59.66 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains.

Therapeutic BCG Vaccines Market Growth Forecast

The therapeutic bcg vaccines market size is expected to see strong growth in the next few years. It will grow to $77.17 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches.

Book your 30 minutes free consultation with our research experts

Therapeutic BCG Vaccines Market Driver: Fighting Tuberculosis Surging Global Cases Propel Growth In The Therapeutic Bcg Vaccine Market

The rising number of tuberculosis (TB) cases worldwide will propel the growth of the therapeutic BCG vaccine market going forward. Tuberculosis (TB) is an infectious illness that can be potentially dangerous and primarily impacts the lungs. People can contract tuberculosis from one another by coughing or sneezing small droplets of bacteria into the air. BCG vaccines are used to stimulate the immune system to fight infection but do not cause TB since the germs are weak. It consistently offers protection against the most dangerous types of TB, such as adolescent TB meningitis. The BCG vaccine protects against tuberculosis which helps to fight against infection, hence the usage of therapeutic BCG vaccines increased. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the rising number of tuberculosis (TB) cases worldwide is driving the growth of the therapeutic BCG vaccine market.

Therapeutic BCG Vaccines Market Driver: Therapeutic BCG Vaccines Rise To The Challenge Amidst Growing Drug-Resistant Tuberculosis Incidence

The rising incidence of drug-resistant TB cases is expected to propel the growth of the therapeutic BCG vaccine market in the coming years. Drug-resistant tuberculosis (TB) is a kind of tuberculosis in which the bacteria responsible for the disease, Mycobacterium tuberculosis, acquire resistance to the medications routinely used to treat the infection. Therapeutic Bacillus Calmette-Guérin (BCG) vaccines, while primarily known for their use in preventing certain forms of tuberculosis (TB), have also been explored in the context of drug-resistant tuberculosis (DR-TB). For instance, in November 2023, according to the Centers for Disease Control and Prevention, a US-based federal agency that works for the Department of Health and Human Services, resistance to at least isoniazid was recorded in 528 (8.4%) of TB cases in the United States in 2022, including 90 (1.4%) multidrug resistance cases. Among those born in the United States, 86 (5.7%) had INH-resistant TB, with 11 (0.7%) having MDR TB. Therefore, the rising incidence of drug-resistant TB cases is driving the therapeutic BCG vaccine market.

Global Therapeutic BCG Vaccines Market Major Players

Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan

Global Therapeutic BCG Vaccines Market Trend: ImmunityBio And Serum Institute Of India Strategic Partnership To Advance Therapeutic Bcg Vaccine Development

Strategic partnerships have emerged as a key trend gaining popularity in the therapeutic BCG vaccine market. Major companies operating in the therapeutic BCG vaccine market are focused on collaborating with other key players to sustain their position in the market. For instance, in May 2024, ImmunityBio, a US-based biotechnology company, partnered with Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, to secure a supply of the Bacillus Calmette-Guerin (BCG) vaccine for all cancer types. The partnership focuses on producing the standard BCG (sBCG) approved for use outside the US and a next-generation recombinant BCG (iBCG) currently undergoing tests. iBCG is intended for use along with ImmunityBio’s ANKTIVA (nogapendekin alfa inbakicept-PMLN) for approved and additional future indications, contingent on regulatory approvals.

Global Therapeutic BCG Vaccines Market Trend: Innovative Therapeutic Applications Of Bcg Immunotherapy

Major companies operating in the therapeutic BCG vaccine market are focused on innovating vaccines for potential therapeutic applications in various medical conditions, such as BCG immunotherapy, to expand their customer base and meet growing patient needs. BCG (Bacillus Calmette-Guérin) immunotherapy refers to the use of the BCG vaccine as a form of immunotherapy to treat certain types of cancer, particularly bladder cancer. For instance, in July 2023, The Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, received government approval to export its BCG vaccine to Canada for immunotherapeutic use in treating bladder cancer. This live freeze-dried preparation, derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is intended for intravenous instillation. The vaccine is available in 40 mg and 80 mg presentations. As an integral part of the therapy, the vaccine is administered directly into the bladder through a catheter, where it remains in the bladder lining for a specified duration. This targeted approach aims to impact cancer cells effectively while minimizing impact on other parts of the body.

Therapeutic BCG Vaccines Market Merger And Acquisition: Sanofi Enhances Oncology Therapeutics Portfolio With Acquisition Of Amunix And Innovative Pro-Xten Technology

In February 2022, Sanofi S.A., a France-based multinational pharmaceutical and healthcare company, acquired Amunix for an undisclosed amount. This acquisition provides access to Amunix Pro-XTEN, XPAT, and XPAC technology to deliver conditionally activated biologics of the next generation. The technology platform supports Sanofi's efforts to accelerate and expand its contributions to cutting-edge therapies for oncology patients, with about 20 compounds presently in development. It is a perfect addition to Sanofi's existing R&D platforms. Amunix is a US-based immuno-oncology company intended to discover, design, and develop novel biologics, proteins, and peptide therapeutics.

Regional Analysis For The Global Therapeutic BCG Vaccines Market

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the therapeutic BCG vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Therapeutic BCG Vaccines Market?

The therapeutic BCG vaccines market consists of sales of vectors, peptides, proteins, DNA, and dendritic cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Therapeutic BCG Vaccines Industry?

The therapeutic BCG vaccines market research report is one of a series of new reports from The Business Research Company that provides therapeutic BCG vaccines market statistics, including therapeutic BCG vaccines industry global market size, regional shares, competitors with a therapeutic BCG vaccines market share, detailed therapeutic BCG vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic BCG vaccines industry. This therapeutic BCG vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Therapeutic BCG Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$59.66 billion
Revenue Forecast In 2034	$77.17 billion
Growth Rate	CAGR of 6.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Therapy BCG, Immune BCG 2) By Demographics: Pediatrics, Adults 3) By End Use: Hospitals, Clinics, Other End Users Subsegments: 1) By Therapy BCG: Intravesical BCG, Injectable BCG 2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Therapeutic BCG Vaccines Market Characteristics

3. Therapeutic BCG Vaccines Market Trends And Strategies

4. Therapeutic BCG Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Therapeutic BCG Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Therapeutic BCG Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Therapeutic BCG Vaccines Market Growth Rate Analysis

5.4. Global Therapeutic BCG Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Therapeutic BCG Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Therapeutic BCG Vaccines Total Addressable Market (TAM)

6. Therapeutic BCG Vaccines Market Segmentation

6.1. Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Therapy BCG

Immune BCG

6.2. Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatrics

Adults

6.3. Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.4. Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Therapy BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravesical BCG

Injectable BCG

6.5. Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Immune BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

BCG For Immune Enhancement

BCG For Allergy Treatment

7. Therapeutic BCG Vaccines Market Regional And Country Analysis

7.1. Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Therapeutic BCG Vaccines Market

8.1. Asia-Pacific Therapeutic BCG Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Therapeutic BCG Vaccines Market

9.1. China Therapeutic BCG Vaccines Market Overview

9.2. China Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Therapeutic BCG Vaccines Market

10.1. India Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Therapeutic BCG Vaccines Market

11.1. Japan Therapeutic BCG Vaccines Market Overview

11.2. Japan Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Therapeutic BCG Vaccines Market

12.1. Australia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Therapeutic BCG Vaccines Market

13.1. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Therapeutic BCG Vaccines Market

14.1. South Korea Therapeutic BCG Vaccines Market Overview

14.2. South Korea Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Therapeutic BCG Vaccines Market

15.1. Western Europe Therapeutic BCG Vaccines Market Overview

15.2. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Therapeutic BCG Vaccines Market

16.1. UK Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Therapeutic BCG Vaccines Market

17.1. Germany Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Therapeutic BCG Vaccines Market

18.1. France Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Therapeutic BCG Vaccines Market

19.1. Italy Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Therapeutic BCG Vaccines Market

20.1. Spain Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Therapeutic BCG Vaccines Market

21.1. Eastern Europe Therapeutic BCG Vaccines Market Overview

21.2. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Therapeutic BCG Vaccines Market

22.1. Russia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Therapeutic BCG Vaccines Market

23.1. North America Therapeutic BCG Vaccines Market Overview

23.2. North America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Therapeutic BCG Vaccines Market

24.1. USA Therapeutic BCG Vaccines Market Overview

24.2. USA Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Therapeutic BCG Vaccines Market

25.1. Canada Therapeutic BCG Vaccines Market Overview

25.2. Canada Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Therapeutic BCG Vaccines Market

26.1. South America Therapeutic BCG Vaccines Market Overview

26.2. South America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Therapeutic BCG Vaccines Market

27.1. Brazil Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Therapeutic BCG Vaccines Market

28.1. Middle East Therapeutic BCG Vaccines Market Overview

28.2. Middle East Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Therapeutic BCG Vaccines Market

29.1. Africa Therapeutic BCG Vaccines Market Overview

29.2. Africa Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Therapeutic BCG Vaccines Market Competitive Landscape And Company Profiles

30.1. Therapeutic BCG Vaccines Market Competitive Landscape

30.2. Therapeutic BCG Vaccines Market Company Profiles

30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Japan BCG Laboratory Overview, Products and Services, Strategy and Financial Analysis

30.2.4. China National Biotec Group Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Therapeutic BCG Vaccines Market Other Major And Innovative Companies

31.1. InterVax Ltd.

31.2. GreenSignal Bio Pharma Limited

31.3. Statens Serum Institute

31.4. AJ Vaccines

31.5. Bul Bio-National Center of Infectious and Parasitic Diseases Ltd

31.6. Biomed Lublin S.A.

31.7. Microgen

31.8. Taj Pharma Ltd.

31.9. PT Bio Farma

31.10. Torlak Institute of Virology

31.11. Bacille Bilie Calmette-Guerin Laboratory

31.12. China Biotechnology Co Ltd.

31.13. Bharat Biotech International Ltd.

31.14. Biological E. Limited

31.15. Shanghai Institute of Biological Products Co. Ltd.

32. Global Therapeutic BCG Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Therapeutic BCG Vaccines Market

34. Recent Developments In The Therapeutic BCG Vaccines Market

35. Therapeutic BCG Vaccines Market High Potential Countries, Segments and Strategies

35.1 Therapeutic BCG Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Therapeutic BCG Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Therapeutic BCG Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Therapy BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Immune BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Merck & Co Inc. Financial Performance

Table 77: Sanofi Pasteur Financial Performance

Table 78: Japan BCG Laboratory Financial Performance

Table 79: China National Biotec Group Financial Performance

Table 80: Serum Institute of India Pvt. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Therapy BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Therapeutic BCG Vaccines Market, Sub-Segmentation Of Immune BCG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Merck & Co Inc. Financial Performance

Figure 77: Sanofi Pasteur Financial Performance

Figure 78: Japan BCG Laboratory Financial Performance

Figure 79: China National Biotec Group Financial Performance

Figure 80: Serum Institute of India Pvt. Ltd. Financial Performance

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oncology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the filgrastim biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the antiglaucoma drugs market research report 2022 with industry size, share, segments and market growth

Wound Care Devices Global Market Report 2025 – By Type (Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2025 – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type (Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types), By End-User (Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pain Management Devices And Therapies Global Market Report 2025 – By Type (Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps), By Neurostimulation Devices (Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices), By Electrical Stimulation Devices (Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Combination Devices, Electrotherapy Devices, TNS), By Ablation Devices (Radiofrequency Ablation Devices, Cryoablation Devices), By Analgesic Infusion Pumps (Intrathecal Infusion Pumps, External Infusion Pumps), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Trauma) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Defibrillator Devices And Equipment Global Market Report 2025 – By Type (Implantable Defibrillators, External defibrillators), By Implantable Defibrillators (Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), Cardiac Resynchronization Therapy- Defibrillator (CRT-D), Single & Dual Chamber), By External defibrillators (Manual External Defibrillator (MEDs), Automated External Defibrillator (AEDs), Wearable Cardioverter Defibrillator (WCDs)), By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2025 – By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), By Application (Bradycardia, Tachycardia, Heart Failure, Other Applications), By End User (Hospitals, Ambulatory surgical centers, Physicians Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Orthobiologics Devices And Equipment Global Market Report 2025 – By Product Type (Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics), By Application (Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery), By End Use (Hospitals, Orthopedic Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transdermal Skin Patches Global Market Report 2025 – By Product (Matrix, Drug In Adhesive, Reservoir, Vapor), By Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types), By Distribution Channel (Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Convalescent Plasma Therapy Global Market Report 2025 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the therapeutic bcg vaccines market?

How will the therapeutic bcg vaccines market drivers and restraints affect the therapeutic bcg vaccines market dynamics? What forces will shape the therapeutic bcg vaccines industry going forward?

The therapeutic bcg vaccines market major growth driver - Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.. For further insights on the therapeutic bcg vaccines market, request a sample here

What is the forecast market size or the forecast market value of the therapeutic bcg vaccines market?

The therapeutic bcg vaccines market size has grown strongly in recent years. It will grow from $56.47 billion in 2024 to $59.66 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains. The therapeutic bcg vaccines market size is expected to see strong growth in the next few years. It will grow to $77.17 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches. For further insights on the therapeutic bcg vaccines market, request a sample here

How is the therapeutic bcg vaccines market segmented?

The therapeutic bcg vaccines market is segmented
1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users Subsegments:
1) By Therapy BCG: Intravesical BCG, Injectable BCG
2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment For further insights on the therapeutic bcg vaccines market, request a sample here

Which region has the largest share of the therapeutic bcg vaccines market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the therapeutic bcg vaccines market, request a sample here.

Who are the major players in the therapeutic bcg vaccines market?

What are the key trends in the therapeutic bcg vaccines market?

Major trend in the therapeutic bcg vaccines market - ImmunityBio And Serum Institute Of India Strategic Partnership To Advance Therapeutic Bcg Vaccine Development. For further insights on the therapeutic bcg vaccines market, request a sample here.

What are the major opportunities in the therapeutic bcg vaccines market? What are the strategies for the therapeutic bcg vaccines market?

For detailed insights on the major opportunities and strategies in the therapeutic bcg vaccines market, request a sample here.

How does the therapeutic bcg vaccines market relate to the overall economy and other similar markets?

For detailed insights on therapeutic bcg vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the therapeutic bcg vaccines industry?

For detailed insights on the mergers and acquisitions in the therapeutic bcg vaccines industry, request a sample here.

What are the key dynamics influencing the therapeutic bcg vaccines market growth? SWOT analysis of the therapeutic bcg vaccines market.

For detailed insights on the key dynamics influencing the therapeutic bcg vaccines market growth and SWOT analysis of the therapeutic bcg vaccines industry, request a sample here.